Dr. Andrew G. Gianoukakis, MD

Dr. Gianoukakis practices at Harbor-UCLA Medical Center in Torrance, California, part of County of Los Angeles.

Dr. Gianoukakis' NPI, 1023083086, was assigned on February 22, 2006. Dr. Gianoukakis graduated from University of Patras School of Medicine in 1993. Dr. Gianoukakis' California license number on file is A79831.

Dr. Gianoukakis' primary practice is Harbor-UCLA Medical Center, at 1000 W Carson St, Torrance, CA 90509 in Los Angeles County. The practice phone is (310) 222-2345.

Dr. Gianoukakis' primary practice is Harbor-UCLA Medical Center in Torrance, California, part of County of Los Angeles. Dr. Gianoukakis is also affiliated with Torrance Memorial Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Gianoukakis to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gianoukakis practices, 4 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Gianoukakis' primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Gianoukakis is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Gianoukakis' licenses on file in 2 states: California and New York.

Dmand AI lists chronic diabetes, high cholesterol, overactive thyroid and underactive thyroid among the conditions Dr. Gianoukakis treats.

CMS data shows 49 Medicare services from Dr. Gianoukakis across 2 procedure codes in 2024, for 18 Medicare patients. Medicare paid $2,579 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Gianoukakis in 2024. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gianoukakis' median patient age at 65, with 64% women.

In 2024, Dr. Gianoukakis wrote 80 Medicare Part D claims for 15 patients. 57% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $6,728 in total drug cost. In 2023, CMS named 46 claims across 2 drugs.

Dr. Gianoukakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gianoukakis as offering telehealth.

Dmand AI links 52 papers to Dr. Gianoukakis, published from 2006 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Thyroid Neoplasms, Iodine Radioisotopes and Thyroid Gland. Dr. Gianoukakis has published most often in Thyroid. Dr. Gianoukakis' most frequent co-authors are Lori J. Wirth, MD, Raymond S. Douglas, MD, PhD and Marcia S. Brose, MD.

Dmand AI links Dr. Gianoukakis to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Medullary, Thyroid cancer, Hurthle cell and Adenocarcinoma, Follicular. Open Payments lists research payments to Dr. Gianoukakis that name 1 trial.

CMS Open Payments shows 103 general payments to Dr. Gianoukakis from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Eisai Inc. paid the most, $48,505. It also lists 1 research payment totaling $15,000 in 2020, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Gianoukakis.

Dr. Gianoukakis graduated from University of Patras School of Medicine in 1993. Dr. Gianoukakis is a member of ENDO.

Dr. Gianoukakis is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.